Options Brief: Cytori Therapeutics (CYTX)

Shares of Cytori Therapeutics CYTX are lower on the session by 3.45%, trading at $5.60. Overall call volume is now running at 3.68x the daily average, with 75% of all calls traded being purchases on the offer. 1,979 contracts have traded on the session so far. Cytori Therapeutics, Inc. develops, manufactures, and sells medical products and devices to enable the practice of regenerative medicine. The company's technology is the Celuion family of products, which processes patients' adipose-derived stem and regenerative cells at the point of care.